https://www.frontiersin.org/article...WEQ4Ga11svDwipyTuBzQuVCxHKBhF00zUeVvCTY7usHos
In this study, we explored the inflammatory proteomic signature of POTS in order to elucidate pathophysiological mechanisms underlying this particular phenotype of cardiovascular autonomic dysfunction. We demonstrated that POTS is associated with lower circulating levels of proprotein convertases subtilisin/kexin type (PCSK)-3, i.e., proconvertase furin. Interestingly, the earlier the disease starts, the lower the proconvertase furin level.
Our findings confirm and further expand the growing body of evidence pointing to an immune dysregulation as the primary pathophysiological mechanism underlying POTS. However, it is noteworthy that pro-inflammatory cytokines and chemokines, i.e., interleukin-7, interleukin-12 and CXC motif chemokine 13, associated with systemic inflammatory diseases such as systemic lupus erythromatosus or rheumatoid arthritis were not increased among POTS-positive patients.
Proteomic profiling by proximity extension technique revealed an inflammation-specific biomarker fingerprint in POTS patients. Circulating levels of proconvertase furin are downregulated in POTS suggesting a complex and intriguing interplay between autoimmune activity and cardiovascular autonomic dysfunction.
In this study, we explored the inflammatory proteomic signature of POTS in order to elucidate pathophysiological mechanisms underlying this particular phenotype of cardiovascular autonomic dysfunction. We demonstrated that POTS is associated with lower circulating levels of proprotein convertases subtilisin/kexin type (PCSK)-3, i.e., proconvertase furin. Interestingly, the earlier the disease starts, the lower the proconvertase furin level.
Our findings confirm and further expand the growing body of evidence pointing to an immune dysregulation as the primary pathophysiological mechanism underlying POTS. However, it is noteworthy that pro-inflammatory cytokines and chemokines, i.e., interleukin-7, interleukin-12 and CXC motif chemokine 13, associated with systemic inflammatory diseases such as systemic lupus erythromatosus or rheumatoid arthritis were not increased among POTS-positive patients.
Proteomic profiling by proximity extension technique revealed an inflammation-specific biomarker fingerprint in POTS patients. Circulating levels of proconvertase furin are downregulated in POTS suggesting a complex and intriguing interplay between autoimmune activity and cardiovascular autonomic dysfunction.